NICE推荐Aucatzyl作为成人淋巴母细胞白血病患者的治疗方案

投资观察
Nov 25, 2025

11月25日 - Autolus Therapeutics PLC宣布,NICE已推荐Aucatzyl®(Obecabtagene Autoleucel)作为成年患者(≥26岁)治疗复发或难治性B细胞前体急性淋巴母细胞白血病(R/R B-ALL)的治疗选项。Autolus Therapeutics PLC计划在英格兰和威尔士迅速推出Aucatzyl。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10